Xu Lining, Zhang Yingyu, Wang Dingding, Ren Quanzhong, Wang Yi, Zang Zetong, Guo Anyi, Guo Jianxun, Wang Ling, Wang Renxian, Liu Yajun
JST Sarcopenia Research Centre, National Center for Orthopaedics, Beijing Research Institute of Traumatology and Orthopaedics, Beijing Jishuitan Hospital, Capital Medical University, Beijing, 100035, China.
Department of Spine Surgery, National Center for Orthopaedics, Beijing Jishuitan Hospital, Capital Medical University, Beijing, 100035, China.
Small. 2025 May;21(18):e2412611. doi: 10.1002/smll.202412611. Epub 2025 Mar 20.
Macrophages are key innate immune cells in the muscle environment of sarcopenia patients, significantly influencing muscle stem cell (MuSC) proliferation and differentiation. However, prolonged activation of macrophages can hinder muscle recovery. In this study, it synthesizes lipoic acid-modified gold nanoparticles (LA-Au NPs) of varying sizes to evaluate their biocompatibility and immunomodulatory effects. The findings demonstrate that LA-Au NPs exhibit excellent biocompatibility with macrophages and promoted M2 polarization in a size-dependent manner. Mechanistically, LA-Au NPs facilitated metabolic reprogramming in macrophages by enhancing lysosomal autophagy and mitochondrial oxidative phosphorylation. Furthermore, macrophages are shown to chemotax toward MuSCs, regulating their proliferation via the chemokine system, inhibiting MuSC apoptosis, and enhancing differentiation under inflammatory conditions. In vivo studies have confirmed the safety and efficacy of LA-Au NPs in sarcopenia mice. To further enhance the effectiveness of LA-Au NPs, it investigates a delivery strategy that involves preconditioning macrophages with LA-Au NPs (Mac@Au NPs). Compared to the direct injection of LA-Au NPs, Mac@Au NPs demonstrate significantly greater benefits for muscle repair. This highlights the potential of macrophage therapy as a promising strategy for effective muscle regeneration and therapeutic intervention in sarcopenia.
巨噬细胞是少肌症患者肌肉环境中的关键固有免疫细胞,对肌肉干细胞(MuSC)的增殖和分化有显著影响。然而,巨噬细胞的长期激活会阻碍肌肉恢复。在本研究中,合成了不同尺寸的硫辛酸修饰金纳米颗粒(LA-Au NPs),以评估其生物相容性和免疫调节作用。研究结果表明,LA-Au NPs与巨噬细胞具有良好的生物相容性,并以尺寸依赖的方式促进M2极化。从机制上讲,LA-Au NPs通过增强溶酶体自噬和线粒体氧化磷酸化促进巨噬细胞的代谢重编程。此外,巨噬细胞被证明可趋化至MuSCs,通过趋化因子系统调节其增殖,抑制MuSC凋亡,并在炎症条件下增强分化。体内研究证实了LA-Au NPs在少肌症小鼠中的安全性和有效性。为进一步提高LA-Au NPs的有效性,研究了一种用LA-Au NPs预处理巨噬细胞的递送策略(Mac@Au NPs)。与直接注射LA-Au NPs相比,Mac@Au NPs对肌肉修复显示出显著更大的益处。这突出了巨噬细胞疗法作为一种有前景的策略,用于少肌症有效肌肉再生和治疗干预的潜力。